SCHEMBL10167571

SCHEMBL10167571

CN(C(=O)Nc1c(F)cccc1F)c1nsc2cccc(Cl)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 3/20 0.39
RAB9A P51151 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 2/20 0.36
GPBAR1 Q8TDU6 1/20 0.35
ALDH1A1 P00352 3/20 0.35
RECQL P46063 1/20 0.35
POLB P06746 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KIT P10721 1/20 0.34
KDR P35968 1/20 0.34
FLT3 P36888 1/20 0.34
MAPT P10636 1/20 0.33
NOX1 Q9Y5S8 1/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167570 0.81 GPBAR1 (0.36) RAB9AMEN1KMT2ANPC1GPBAR1
SCHEMBL357034 0.80 OGG1 (0.36) RAB9ANPC1ALDH1A1POLBKDM4E
SCHEMBL350288 0.79 POLB (0.39) RAB9AMEN1KMT2ANPC1GPBAR1
SCHEMBL4387156 0.77 POLB (0.38) GPBAR1ALDH1A1POLBKDM4ECYP3A4
SCHEMBL10167454 0.77 POLB (0.35) GPBAR1ALDH1A1POLBKDM4EKIT
SCHEMBL10167447 0.75 ALDH1A1 (0.40) KMT2AGPBAR1ALDH1A1POLBKDM4E
SCHEMBL10167464 0.74 LMNA (0.45) RAB9AKMT2ANPC1GPBAR1ALDH1A1
SCHEMBL10167451 0.74 HSD17B1 (0.37) GPBAR1ALDH1A1POLBKDM4EMAPT
SCHEMBL10167565 0.73 ALDH1A1 (0.38) MEN1KMT2AGPBAR1ALDH1A1POLB
SCHEMBL10167449 0.73 ALDH1A1 (0.38) RAB9AALDH1A1POLBKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
WO-2008090048-A2 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BPNT1, BCAT1, TGFBR1 LCK 2507/4885RAB9A 1949/4885MEN1 3020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.